(SSNC) SS&C Technologies Holdings - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US78467J1007
Stock: Portfolio, Trading, Healthcare, Reconciliation, Consulting
Total Rating 27
Risk 74
Buy Signal -0.02
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.22% |
| Yield on Cost 5y | 1.61% |
| Yield CAGR 5y | 11.21% |
| Payout Consistency | 100.0% |
| Payout Ratio | 33.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 50.3% |
| Relative Tail Risk | -4.37% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.18 |
| Alpha | -18.10 |
| Character TTM | |
|---|---|
| Beta | 0.843 |
| Beta Downside | 0.946 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.06% |
| CAGR/Max DD | 0.41 |
Description: SSNC SS&C Technologies Holdings December 19, 2025
SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) delivers a vertically integrated suite of software and software-enabled services to the financial services and healthcare sectors, covering the full workflow from front-office trading and modeling through middle-office portfolio management to back-office accounting, compliance, and clearing, as well as claims adjudication and care-management tools for health providers.
In FY 2023 the company reported revenue of roughly $6.5 billion, a year-over-year increase of about 8%, driven by strong growth in its SaaS-based investment-management platform (ARR now exceeds $5.5 billion). The client base exceeds 8,000 institutions, and operating margins have improved to ~14% as the firm scales its managed services and data-solution offerings. A key sector driver is the accelerating migration of asset managers to cloud-native, low-latency trading and compliance suites, which is bolstered by regulatory pressure for real-time reporting and by fee-compression trends that favor cost-efficient technology partners.
For a deeper quantitative view, the ValueRay platform offers granular financial metrics and peer comparisons worth exploring.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 852.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.75 > 1.0 |
| NWC/Revenue: 9.02% < 20% (prev 11.64%; Δ -2.62% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.56b > Net Income 852.0m |
| Net Debt (6.42b) to EBITDA (2.13b): 3.01 < 3 |
| Current Ratio: 1.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (253.1m) vs 12m ago -0.39% < -2% |
| Gross Margin: 48.56% > 18% (prev 0.49%; Δ 4807 % > 0.5%) |
| Asset Turnover: 32.42% > 50% (prev 31.26%; Δ 1.16% > 0%) |
| Interest Coverage Ratio: 3.27 > 6 (EBITDA TTM 2.13b / Interest Expense TTM 439.0m) |
Altman Z'' 1.69
| A: 0.03 (Total Current Assets 5.32b - Total Current Liabilities 4.77b) / Total Assets 19.49b |
| B: 0.21 (Retained Earnings 4.05b / Total Assets 19.49b) |
| C: 0.08 (EBIT TTM 1.43b / Avg Total Assets 18.96b) |
| D: 0.30 (Book Value of Equity 3.75b / Total Liabilities 12.50b) |
| Altman-Z'' Score: 1.69 = BB |
Beneish M -2.70
| DSRI: 1.44 (Receivables 4.69b/3.06b, Revenue 6.15b/5.76b) |
| GMI: 1.01 (GM 48.56% / 49.08%) |
| AQI: 0.92 (AQ_t 0.70 / AQ_t-1 0.76) |
| SGI: 1.07 (Revenue 6.15b / 5.76b) |
| TATA: -0.04 (NI 852.0m - CFO 1.56b) / TA 19.49b) |
| Beneish M-Score: -2.70 (Cap -4..+1) = A |
What is the price of SSNC shares?
As of February 07, 2026, the stock is trading at USD 77.39 with a total of 5,415,248 shares traded.
Over the past week, the price has changed by -5.50%, over one month by -12.74%, over three months by -7.99% and over the past year by -4.23%.
Over the past week, the price has changed by -5.50%, over one month by -12.74%, over three months by -7.99% and over the past year by -4.23%.
Is SSNC a buy, sell or hold?
SS&C Technologies Holdings has received a consensus analysts rating of 4.33.
Therefore, it is recommended to buy SSNC.
- StrongBuy: 6
- Buy: 4
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SSNC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 100.8 | 30.2% |
| Analysts Target Price | 100.8 | 30.2% |
| ValueRay Target Price | 80.8 | 4.4% |
SSNC Fundamental Data Overview February 05, 2026
P/E Trailing = 21.8071
P/E Forward = 11.1732
P/S = 2.9191
P/B = 2.5898
P/EG = 0.822
Revenue TTM = 6.15b USD
EBIT TTM = 1.43b USD
EBITDA TTM = 2.13b USD
Long Term Debt = 6.57b USD (from longTermDebt, last quarter)
Short Term Debt = 20.0m USD (from shortTermDebt, last quarter)
Debt = 6.81b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.42b USD (from netDebt column, last quarter)
Enterprise Value = 24.37b USD (17.95b + Debt 6.81b - CCE 388.3m)
Interest Coverage Ratio = 3.27 (Ebit TTM 1.43b / Interest Expense TTM 439.0m)
EV/FCF = 15.01x (Enterprise Value 24.37b / FCF TTM 1.62b)
FCF Yield = 6.66% (FCF TTM 1.62b / Enterprise Value 24.37b)
FCF Margin = 26.40% (FCF TTM 1.62b / Revenue TTM 6.15b)
Net Margin = 13.86% (Net Income TTM 852.0m / Revenue TTM 6.15b)
Gross Margin = 48.56% ((Revenue TTM 6.15b - Cost of Revenue TTM 3.16b) / Revenue TTM)
Gross Margin QoQ = 47.69% (prev 47.95%)
Tobins Q-Ratio = 1.25 (Enterprise Value 24.37b / Total Assets 19.49b)
Interest Expense / Debt = 1.53% (Interest Expense 104.2m / Debt 6.81b)
Taxrate = 17.13% (43.5m / 253.9m)
NOPAT = 1.19b (EBIT 1.43b * (1 - 17.13%))
Current Ratio = 1.12 (Total Current Assets 5.32b / Total Current Liabilities 4.77b)
Debt / Equity = 0.98 (Debt 6.81b / totalStockholderEquity, last quarter 6.93b)
Debt / EBITDA = 3.01 (Net Debt 6.42b / EBITDA 2.13b)
Debt / FCF = 3.95 (Net Debt 6.42b / FCF TTM 1.62b)
Total Stockholder Equity = 6.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.49% (Net Income 852.0m / Total Assets 19.49b)
RoE = 12.54% (Net Income TTM 852.0m / Total Stockholder Equity 6.80b)
RoCE = 10.72% (EBIT 1.43b / Capital Employed (Equity 6.80b + L.T.Debt 6.57b))
RoIC = 8.72% (NOPAT 1.19b / Invested Capital 13.62b)
WACC = 6.89% (E(17.95b)/V(24.75b) * Re(9.02%) + D(6.81b)/V(24.75b) * Rd(1.53%) * (1-Tc(0.17)))
Discount Rate = 9.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.20%
[DCF Debug] Terminal Value 82.21% ; FCFF base≈1.39b ; Y1≈1.37b ; Y5≈1.43b
Fair Price DCF = 105.0 (EV 32.05b - Net Debt 6.42b = Equity 25.63b / Shares 244.0m; r=6.89% [WACC]; 5y FCF grow -1.72% → 2.90% )
EPS Correlation: -35.51 | EPS CAGR: -48.14% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.48 | Revenue CAGR: 5.25% | SUE: 1.02 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.62 | Chg30d=-0.010 | Revisions Net=-2 | Analysts=7
EPS next Year (2026-12-31): EPS=6.61 | Chg30d=-0.023 | Revisions Net=-3 | Growth EPS=+8.9% | Growth Revenue=+5.8%
P/E Forward = 11.1732
P/S = 2.9191
P/B = 2.5898
P/EG = 0.822
Revenue TTM = 6.15b USD
EBIT TTM = 1.43b USD
EBITDA TTM = 2.13b USD
Long Term Debt = 6.57b USD (from longTermDebt, last quarter)
Short Term Debt = 20.0m USD (from shortTermDebt, last quarter)
Debt = 6.81b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.42b USD (from netDebt column, last quarter)
Enterprise Value = 24.37b USD (17.95b + Debt 6.81b - CCE 388.3m)
Interest Coverage Ratio = 3.27 (Ebit TTM 1.43b / Interest Expense TTM 439.0m)
EV/FCF = 15.01x (Enterprise Value 24.37b / FCF TTM 1.62b)
FCF Yield = 6.66% (FCF TTM 1.62b / Enterprise Value 24.37b)
FCF Margin = 26.40% (FCF TTM 1.62b / Revenue TTM 6.15b)
Net Margin = 13.86% (Net Income TTM 852.0m / Revenue TTM 6.15b)
Gross Margin = 48.56% ((Revenue TTM 6.15b - Cost of Revenue TTM 3.16b) / Revenue TTM)
Gross Margin QoQ = 47.69% (prev 47.95%)
Tobins Q-Ratio = 1.25 (Enterprise Value 24.37b / Total Assets 19.49b)
Interest Expense / Debt = 1.53% (Interest Expense 104.2m / Debt 6.81b)
Taxrate = 17.13% (43.5m / 253.9m)
NOPAT = 1.19b (EBIT 1.43b * (1 - 17.13%))
Current Ratio = 1.12 (Total Current Assets 5.32b / Total Current Liabilities 4.77b)
Debt / Equity = 0.98 (Debt 6.81b / totalStockholderEquity, last quarter 6.93b)
Debt / EBITDA = 3.01 (Net Debt 6.42b / EBITDA 2.13b)
Debt / FCF = 3.95 (Net Debt 6.42b / FCF TTM 1.62b)
Total Stockholder Equity = 6.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.49% (Net Income 852.0m / Total Assets 19.49b)
RoE = 12.54% (Net Income TTM 852.0m / Total Stockholder Equity 6.80b)
RoCE = 10.72% (EBIT 1.43b / Capital Employed (Equity 6.80b + L.T.Debt 6.57b))
RoIC = 8.72% (NOPAT 1.19b / Invested Capital 13.62b)
WACC = 6.89% (E(17.95b)/V(24.75b) * Re(9.02%) + D(6.81b)/V(24.75b) * Rd(1.53%) * (1-Tc(0.17)))
Discount Rate = 9.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.20%
[DCF Debug] Terminal Value 82.21% ; FCFF base≈1.39b ; Y1≈1.37b ; Y5≈1.43b
Fair Price DCF = 105.0 (EV 32.05b - Net Debt 6.42b = Equity 25.63b / Shares 244.0m; r=6.89% [WACC]; 5y FCF grow -1.72% → 2.90% )
EPS Correlation: -35.51 | EPS CAGR: -48.14% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.48 | Revenue CAGR: 5.25% | SUE: 1.02 | # QB: 2
EPS next Quarter (2026-03-31): EPS=1.62 | Chg30d=-0.010 | Revisions Net=-2 | Analysts=7
EPS next Year (2026-12-31): EPS=6.61 | Chg30d=-0.023 | Revisions Net=-3 | Growth EPS=+8.9% | Growth Revenue=+5.8%